Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
This grant funds research aimed at analyzing and integrating existing data to better understand cancer risk and related outcomes.
About this program
The Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes grant supports innovative research that utilizes existing datasets to explore cancer risk factors and outcomes. This funding opportunity is designed for researchers who can leverage previously collected data to generate new insights into cancer epidemiology and improve public health strategies. The goal is to enhance our understanding of cancer through secondary data analysis, which can lead to more effective prevention and treatment strategies. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that have the capability to conduct rigorous data analysis. The grant encourages collaboration among researchers from various disciplines to foster a comprehensive approach to cancer research. By integrating diverse datasets, applicants can uncover patterns and correlations that may not be evident from single-source studies, ultimately contributing to the body of knowledge in cancer risk assessment and management.
Eligibility
Academic institutions, nonprofit organizations, and research entities capable of conducting data analysis.